Furthermore, CD73 can affect the AKT/GSK-3β/β-catenin signaling pathway through A2aR by inducing the cyclinD1 activation to alter the cell cycle status of cancer cells and promote tumorigenesis [36]. This evidence concerns the gene NT5E and cancer.